• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$88.59 -$0.06 (-0.07%)

REAL-TIME: Last trade at

Shire plc (ADR)

NASDAQ:SHPGY

Jump to this page for:

Related Resources

KemPharm Inc. Focuses on Advanced Pain Management Franchise

5/22/2012 by GlobeNewswire

Professional Baseball Player Shane Victorino Raises Awareness of Attention-Deficit/Hyperactivity Disorder in Young Adults and Adults Through "Own It" Initiative

5/21/2012 by PR Newswire

Industrial Wireless: Improving the Flexibility of Pharmaceutical Plants

5/15/2012 by Pharmaceutical Processing

Promedior Moves Fibrosis Pipeline to Boston, Hires Shire plc Vet as CEO

5/15/2012 by BioSpace

Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th

5/14/2012 by StockWatch

Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th

5/14/2012 by PR Newswire

M&S boosted by 'ageing demographic' tip

5/11/2012 by FT.com

Shire upgraded to Outperform from Neutral at Exane BNP Paribas

5/11/2012 by Theflyonthewall.com

Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases% Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation

5/10/2012 by PR Newswire

Weight Loss Battle Heats Up For Investors

5/10/2012 by Seeking Alpha

Watson Pharmaceuticals confirms Lialda patent challenge

5/9/2012 by Theflyonthewall.com

Leerink's pharmaceuticals analyst holds a conference call

5/9/2012 by Theflyonthewall.com

Shire Q1 net income increases

5/4/2012 by Datamonitor

Sangamo's CEO Discusses Q1 2012 Results - Earnings Call Transcript

5/2/2012 by Seeking Alpha

Vyvanse Evaluated for Binge Eating

5/1/2012 by Drug Discovery & Development

Shire's stumble could help Protalix on Gaucher's treatment

4/29/2012 by Globes - Israel

Revenues Rise at Shire

4/27/2012 by Zacks Equity Research Analyst Blog

Revenues Rise at Shire - Analyst Blog

4/27/2012 by NASDAQ

Revenues Rise at Shire - Analyst Blog

4/27/2012 by Zacks Investment Research

Shire 1Q profit grows as ADHD drug sales rise

4/26/2012 by Bioscience Technology

Weir finds support from short coverers

4/26/2012 by FT.com

Brennan's departure opens door to change

4/26/2012 by FT.com

Attention deficit drugs sales boost Shire

4/26/2012 by FT.com

Shire sees good earnings momentum as profit rises

4/26/2012 by MarketWatch

Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth

4/26/2012 by PR Newswire

Shire: Phase 2 study met primary end point for investigative yse of Vyvanse

4/26/2012 by Theflyonthewall.com

Shire Reports Positive Phase 2 Study Met Primary End Point for Investigative Use of Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) in Adults with Binge Eating Disorder

4/26/2012 by PR Newswire

Under Armour, Shire Plc. Among Stocks…

4/20/2012 by FOX - Fox 5 - Washington DC

Under Armour, Shire Plc. Among Stocks Up on High Volume Friday

4/20/2012 by FOXBusiness.com

Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest

4/20/2012 by PR Newswire

Shire to Buy Pervasis Therapeutics - Analyst Blog

4/18/2012 by Zacks Investment Research

Shire to Buy Pervasis Therapeutics

4/18/2012 by Zacks Equity Research Analyst Blog

Shire Adds New Technology Platform And Phase 2 Product Candidate To Its Regenerative Medicine Business

4/16/2012 by Biocompare

Shire likely to win Adderall patent dispute over Waston, says Leerink

4/13/2012 by Theflyonthewall.com

Shire to Acquire Assets of Pervasis Therapeutics

4/13/2012 by Pharmaceutical Processing

Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012

4/12/2012 by PharmiWeb.com - UK

Shire makes another biotech acquisition - this time in Mass.

4/12/2012 by Boston Business Journal - Boston MA

Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012

4/12/2012 by PR Newswire

Shire (SHPGY) Adds New Technology Platform, Phase 2 Product Candidate to Regenerative Unit

4/12/2012 by StreetInsider.com

Shire signs agreement to acquire Pervasis Therapeutics assets

4/12/2012 by Theflyonthewall.com
See More Articles...